Blood glucose concentration control is a classic negative feedback problem with insulin secreted by the pancreas as a control variable. Type 1 Diabetes is a chronic metabolic disease caused by a cellular-mediated autoimmune destruction of the pancreas beta-cells, so exogenous insulin administration is needed to regulate the glycaemia. Postprandial glucose regulation is typically based on the knowledge of an estimation of the ingested carbohydrates, of the Carbohydrate-to-insulin ratio, of the correction factor, of the insulin still active and of a measure of the glycaemia just before the meal. Despite the use of this information meal compensation is yet a key unsolved issue. In this letter a new approach based on machine-learning methodolog...
Type 1 diabetes (T1D) therapy requires multiple daily insulin injections to compensate the lack of e...
Recent technological progress in insulin pumps and continuous glucose monitors (CGM) are enabling de...
Background For an effective artificial pancreas (AP) system and an improved therapeutic intervention...
Type 1 Diabetes (T1D) is an autoimmune disease that affects millions of people worldwide. A critical...
Type 1 diabetes (T1D) is an autoimmune disease that affects millions of people worldwide. A most cha...
In the daily management of type 1 diabetes (T1D), determining the correct insulin dose to be injecte...
Accurate continuous glucose monitoring (CGM) is essential for fully automated glucose control in dia...
Meal compensation in blood glucose control of people affected by type 1 Diabetes is an open challeng...
People with type 1 diabetes (T1D) face the challenge of administering exogenous insulin to maintain ...
The artificial pancreas (AP) system is designed to regulate blood glucose in subjects with type 1 di...
Current glucose control systems automatically regulate basal insulin infusion, but users still need ...
Physical activities have a significant impact on blood glucose homeostasis of patients with type 1 d...
In this thesis I propose a novel method to estimate the dose and injection-to-meal time for low-risk...
Current artificial pancreas (AP) systems are hybrid closed-loop systems that require manual meal ann...
Diabetes mellitus is a lifelong disease in which either the pancreas fails to produce insulin or the...
Type 1 diabetes (T1D) therapy requires multiple daily insulin injections to compensate the lack of e...
Recent technological progress in insulin pumps and continuous glucose monitors (CGM) are enabling de...
Background For an effective artificial pancreas (AP) system and an improved therapeutic intervention...
Type 1 Diabetes (T1D) is an autoimmune disease that affects millions of people worldwide. A critical...
Type 1 diabetes (T1D) is an autoimmune disease that affects millions of people worldwide. A most cha...
In the daily management of type 1 diabetes (T1D), determining the correct insulin dose to be injecte...
Accurate continuous glucose monitoring (CGM) is essential for fully automated glucose control in dia...
Meal compensation in blood glucose control of people affected by type 1 Diabetes is an open challeng...
People with type 1 diabetes (T1D) face the challenge of administering exogenous insulin to maintain ...
The artificial pancreas (AP) system is designed to regulate blood glucose in subjects with type 1 di...
Current glucose control systems automatically regulate basal insulin infusion, but users still need ...
Physical activities have a significant impact on blood glucose homeostasis of patients with type 1 d...
In this thesis I propose a novel method to estimate the dose and injection-to-meal time for low-risk...
Current artificial pancreas (AP) systems are hybrid closed-loop systems that require manual meal ann...
Diabetes mellitus is a lifelong disease in which either the pancreas fails to produce insulin or the...
Type 1 diabetes (T1D) therapy requires multiple daily insulin injections to compensate the lack of e...
Recent technological progress in insulin pumps and continuous glucose monitors (CGM) are enabling de...
Background For an effective artificial pancreas (AP) system and an improved therapeutic intervention...